Clinical Trial Search

Primary: Medication for Opioid Use Disorder (MOUD) Knowledge Score — 83.5; 72.0 percentage of correct answers

Primary: Change From Baseline in Monthly Migraine Days During the Last 4 Weeks of the 12-week Treatment Period — -8.19; -6.62 days — p=0.015

Primary: Emergency Room Visits — 40; 33 Emergency Room Visits

Primary: Percentage of Participants With Completion of Imaging With the NUVISION NAV Ultrasound Catheter Without Resort to Non-study Mapping Catheter — 100.0 Percentage of…

Primary: Network Contact Test Uptake — 5; 2 Participants — p=0.45

Primary: Number of Participants With Dose Limiting Toxicities — 0; 0; 0; 0 Participants

Primary: Treatment Response (Phase 1) — 94 Participants

Primary: Symptoms of Agitation as Measured by the Pittsburgh Agitation Scale — 7.14; 5.55; 5.69; 4.97 score on a scale — p=.015

Primary: Percentage of Cogito Participants Reported Being Satisfied — 52 percentage of participants

Primary: Mean Pain Scores at 3 Months — 2.4; 2.4; 1.9; 1.9 scores on a scale

Primary: Number of Subjects in Which the ECG Signal is Interpretable at the Nominal Location and up to 3 Alternate Positions — 49; 49; 49; 49 Participants

Primary: In-hospital Mortalities — 181; 265 Participants

Primary: Number of Participants Successfully Scanned Using F-FMISO-PET Imaging — 18; 5 Participants

Primary: Number of Participants With 7-day Point-prevalence Abstinence From Smoking — 11; 13 Participants

Primary: PAD Cohort: Primary Safety Outcome: Device-related Seroma or Infection — 0 percentage of participants